Get started
Author

Ágnes Bilecz

Observed names: Agnes Bilecz, Bilecz, Ágnes
OpenAlex ID: A5024112359
Vessel co‐option is common in human lung metastases and mediates resistance to anti‐angiogenic therapy in preclinical lung metastasis models
2016 · Victoria L Bridgeman, Peter B Vermeulen, et al. · The Journal of Pathology · 219
PDF
Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2020 · Christine Pirker, Agnes Bilecz, et al. · Clinical Cancer Research · 44
The plasma membrane C a2+ pump PMCA 4b inhibits the migratory and metastatic activity of BRAF mutant melanoma cells
2016 · Luca Hegedũs, Tamás Garay, et al. · International Journal of Cancer · 35
PDF
HunCRC: annotated pathological slides to enhance deep learning applications in colorectal cancer screening
2022 · Bálint Ármin Pataki, Alex Olar, et al. · Scientific Data · 33
PDF
Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study
2021 · Luka Brcic, Thomas Klikovits, et al. · Translational Lung Cancer Research · 31
PDF
DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells
2018 · Johannes Laengle, Judith Stift, et al. · Theranostics · 29
PDF
Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma
2020 · Agnes Bilecz, Paul Stockhammer, et al. · Histopathology · 20
PDF
The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition
2022 · Luca Hegedüs, Elisabeth Livingstone, et al. · International Journal of Molecular Sciences · 10
PDF
Supplementary Figure S6 from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
Supplementary Tables S1-S5 and S7-S9 from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
Supplementary Figure S3 from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
Supplementary Figure S7 from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
Supplementary Figure S8 from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
Supplementary Table S6 from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
Supplementary Figure S9 from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
Data from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
Data from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
Supplementary Material and Methods from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
Supplementary Figure S2 from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
Supplementary Figure S1 from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
Supplementary Figure S5 from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
Supplementary Figure S4 from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
Supplementary Figure S1 from Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
2023 · Christine Pirker, Agnes Bilecz, et al.
patches and local annotations, slide 105, zoom 248x248 um2
2022 · Pataki, Bálint, Olar, Alex, et al. · Figshare
patches and local annotations, slide 015, zoom 124x124 um2
2022 · Pataki, Bálint, Olar, Alex, et al. · Figshare
Works count: 453
Citation count: 421
H-index: 8
I10-index: 8
Year
Topic
Type